FITB vs ORMP
Fifth Third Bancorp (FITB) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
FITB does not have a complete income-statement cache yet.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the FITB and ORMP stock pages for the full models.
Not investment advice.